During embryonic development of the Drosophila brain, the Hox gene labial is required for the regionalized specification of the tritocerebral neuromere. In order to gain further insight into the mechanisms of Hox gene action in the CNS, we have studied the molecular and genetic basis of cross-regulatory interactions between labial and other more posterior Hox genes using the GAL4/UAS system for targeted misexpression. Misexpression of posterior Hox genes in the embryonic neuroectoderm results in a labial loss-of function phenotype and a corresponding lack of Labial protein expression in the tritocerebrum. This is due to repression of labial gene transcription in the embryonic brain. Enhancer analysis suggests that this transcriptional repression operates on a 3.65 kb brain-specific labial-enhancer element. A functional analysis of Antennapedia and Ultrabithorax protein domains shows that the transcriptional repression of labial requires homeodomain-DNA interactions but is not dependent on a functional hexapeptide. The repressive activity of a Hox protein on labial expression in the tritocerebrum can, however, be abolished by concomitant misexpression of a Hox protein and the cofactors Homothorax and nuclear-targeted Extradenticle. Taken together, these results provide novel and detailed insight into the cross-regulatory interactions of Hox genes in embryonic brain development and suggest that specification of tritocerebral neuronal identity requires equilibrated levels of a Hox protein and Hth and n-Exd cofactors. q
Introduction
The homeotic or Hox genes encode a network of conserved transcription factors that are involved in specifying segmental identity along the anteroposterior body axis of animals as diverse as insects and vertebrates (McGinnis and Krumlauf, 1992; Manak and Scott, 1994; Carroll, 1995) . Their functional role in insect development has been studied in detail in Drosophila, where the genes are arranged along the chromosome in two gene clusters known as the Antennapedia (Antp-C) and Bithorax (BX-C) complexes. There is a correlation between the relative position of the Hox genes in the clusters and their spatial and temporal expression patterns in the embryo in that genes located towards the 3 0 end of their complexes are expressed more anteriorly and earlier than genes towards the 5 0 end; this is referred to as spatial and temporal colinearity. Furthermore, Hox genes have been shown to interact both genetically and molecularly, and the term posterior dominance has been proposed to describe the cross-regulation of these genes and the phenotypic consequences of their expression (Duboule and Morata, 1994; Graba et al., 1997; Mann and Morata, 2000) . Hox gene transcription factors often bind to DNA as a heterodimer with another homeodomain protein encoded by the extradenticle (exd) gene. When the Exd cofactor binds together with Hox proteins, it increases their DNA binding specificity and affinity, and also modifies their transcriptional regulatory properties (Mann and Chan, 1996; Pinsonneault et al., 1997) . A further homeodomain protein that is thought to interact with Exd/Hox heterodimers is encoded by the homothorax (hth) gene. Hth and Exd proteins directly interact with each other and the nuclear localization of Exd depends on this interaction (Mann and Affolter, 1998; Ryoo et al., 1999) .
In the developing central nervous system (CNS) of Drosophila, Hox genes are expressed in an anteroposterior ordered set of domains, and in the embryonic brain, specific Hox genes are expressed in the tritocerebrum, the posterior neuromere of the supraesophageal ganglion, and in the three subesophageal neuromeres (reviewed in Hirth and Reichert, 1999) . Initial loss-and gain-of-function studies revealed that cross-regulatory interactions among Hox genes also occur in the developing CNS. Thus, a regulatory hierarchy of transcriptional repression appears to act on the genes Antennapedia (Antp) and Ultrabithorax (Ubx), in that Hox genes expressed more posteriorly act as negative regulators of Hox genes that are expressed in more anterior regions of the embryonic CNS (reviewed in Doe and Scott, 1988) . However, a lack of phenotypic consequences challenged the view that these interactions appear to play a role in determining segmental identity in the embryonic CNS of Drosophila.
Subsequent detailed loss-of-function analyses showed that only the Hox genes labial (lab) and Deformed (Dfd) are involved in regionalization of the embryonic brain, whereas mutations in other Hox genes do not lead to any obvious defects during this process of brain development (Hirth et al., 1998) . Thus, lab null mutants show marked defects in the tritocerebral neuromere where Lab is normally expressed. In these mutants, the tritocerebral commissure is missing and the longitudinal connectives that interconnect the tritocerebrum with posterior parts of the brain, are absent or reduced. Moreover, the cells in the lab mutant domain do not acquire a neuronal identity indicating that lab is required for the specification of neuronal identity in the tritocerebrum (Hirth et al., 1998) . In addition, mutational inactivation of exd or hth encoded cofactors correlate with the absence of lab expression (Nagao et al., 2000) , implying that interactions between lab and these two cofactors occur in the developing tritocerebrum.
More recently, misexpression studies using the Gal4/UAS-system (Brand and Perrimon, 1993) revealed that ectopic Hox genes repress only lab and Sex combs reduced (Scr) in the CNS in a timing dependent manner , suggesting that expression of these genes in the developing CNS is subject to posterior dominance cross-regulatory interactions. Since lab (in contrast to Scr) appears to be involved in the specification of tritocerebral neuronal identity, an investigation of these interactions presents an excellent opportunity to analyse the mechanisms underlying cross regulatory interactions during embryonic brain development of Drosophila.
In this report, we analyse the molecular and genetic basis of cross-regulatory interactions between lab and other more posterior Hox genes using the GAL4/UAS system (Brand and Perrimon, 1993) for targeted misexpression of Hox genes. We find that misexpression of posterior Hox genes such as Antp, Ubx and abd-A results in a lab loss-of function phenotype in the developing tritocerebrum, and that this is correlated with a lack of Lab protein expression in the tritocerebrum. Moreover, we show that this lack of Lab protein is due to transcriptional repression of the lab gene in the embryonic brain during the time period at which Lab is normally required to specify tritocerebral identity. A functional analysis of protein domains involved in Hox specificity shows that transcriptional repression of lab requires homeodomain -DNA interactions. Moreover, the repressive activity that underlies this posterior dominance effect on lab expression can be abolished by the concomitant targeted misexpression of a Hox gene and the cofactors Hth and nuclear-targeted Exd (n-Exd).
Results
To reveal potential cross-regulatory effects of posterior Hox genes on lab expression in the embryonic brain, the GAL4/UAS system was used for targeted misexpression of Hox proteins during embryonic development. Three separate neuronal lineage-specific Gal4 drivers with distinct spatial and temporal expression patterns were used to stimulate transcription from the various Hox responders in the developing embryonic CNS. These were sca < Gal4 (Klaes et al., 1994) , which expresses Gal4 during neuroectoderm specification and neuroblast formation; 1407 < Gal4 (Broadie et al., 1995) , which expresses Gal4 during neuroblast and ganglion mother cell formation, and C155 elav < Gal4 (Lin and Goodman, 1994) , which expresses Gal4 in postmitotic neurons (Fig. 1) .
Targeted misexpression of Hox genes using the 1407 < Gal4 driver or the C155 elav < Gal4 driver did not result in an obvious mutant phenotype in the developing tritocerebrum. In contrast, misexpression of Hox genes using the sca < Gal4 driver resulted in a robust and reproducible mutant phenotype in the embryonic tritocerebrum. This indicates that early, neuroectoderm-specific misexpression of Hox genes, but not later misexpression of Hox genes in neuroblasts, ganglion mother cells or differentiated neurons, leads to the mutant brain phenotype. The mutant phenotype caused by early Hox gene misexpression was observed at high penetrance for all of the Hox genes with the exception of the lab gene. In terms of mutant phenotype penetrance, all Bithorax-complex genes had values above 95% ðn . 60Þ; whereas all Antp-complex genes (excepting lab) had values of 70-80% ðn . 60Þ; and lab had a value of 25% ðn ¼ 75Þ (data not shown). The mutant phenotype caused by early Hox gene misexpression is shown in Fig. 2 exemplary for targeted misexpression of the Ubx gene.
A detailed analysis of the mutant phenotype produced in the developing tritocerebrum by misexpression of posterior Hox genes using the sca < Gal4 driver revealed defects that phenocopied the lab loss-of-function mutation (Fig. 3) .
Thus, marked defects in axonal patterning associated with the tritocerebral neuromere were seen which were identical to those found in lab null mutants (Hirth et al., 1998) . The longitudinal connectives that normally run through this neuromere were missing or reduced and the tritocerebral commissure, which interconnects the brain hemispheres at the level of the tritocerebrum was completely absent. Also, the frontal connectives no longer projected into the tritocerebral neuromere but rather grew ectopically into the more anterior brain neuromeres. In lab null mutants, the cells in the mutant domain of the tritocerebrum no longer express the neuron-specific RNA-binding protein Elav due to a lack of neuronal identity (Hirth et al., 1998) . This was also the case when posterior Hox genes such as Ubx were misexpressed using the sca < Gal4 driver (Fig. 3) ; anti-ELAV immunostaining was no longer seen in any of the cells in the tritocerebral lab domain, but continued to be expressed in all other neuronal cells of the embryonic brain. An alternative glial fate does not appear to be adopted by the affected cells, since expression of the glial-specific repo gene is seen in cells in the affected part of the tritocerebrum. The repo-expressing glial cells are, however, reduced in number and/or misplaced, but they are not totally absent.
The similarity of the phenotype observed in sca < Gal4/UAS < Hox embryonic brains to that seen in lab null mutants suggests that this phenotype may be due to a suppression of Lab protein in the affected domain. To investigate this, we studied expression of Lab protein in the tritocerebrum by immunocytochemistry in wildtype and in sca < Gal4/UAS < Hox embryos. In contrast to the pronounced expression of Lab in the posterior tritocerebral domain of wildtype embryos, a total absence of Lab immunoreactivity was observed in the corresponding domain as exemplified by sca < Gal4/UAS < Ubx embryos (Fig. 4) . (Endoderm-specific, expression of lab in the midgut was ectopically expanded anteriorly in these embryos.) Similar effects on Lab protein expression were seen for misexpression of all other posterior Hox genes under the control of the sca < Gal4 driver (data not shown). These results are in accordance with findings on the regulation of Lab protein expression by ectopic Hox proteins reported by Miller et al. (2001) .
The suppression of Lab protein expression in the tritocerebral domain of sca < Gal4/UAS < Hox embryonic brains could act at the level of translation or transcription. To investigate this, we carried out in situ hybridization studies using a lab-specific RNA probe (Fig. 5 ). In the wildtype, lab transcription is first observed at stage 9 in the neurogenic region of the intercalary segment that gives rise to the tritocerebrum. Subsequently, lab expressing neuroblasts delaminate from this region and generate neuronal progeny (Urbach and Technau, 2003) , some of which continue to express the lab gene throughout embryogenesis (Hirth et al., 1998) . In sca < Gal4/UAS < Ubx embryos, initiation of lab transcription is seen at stage 9 in the neurogenic region of the intercalary segment that gives rise to the tritocerebrum. However, subsequently, lab transcripts disappear in the developing tritocerebrum and by stage 10/11 are completely absent in the developing brain. This absence of lab transcript in the developing brain of sca < Gal4/UAS < Ubx embryos continues throughout embryogenesis. (Endoderm-specific transcription of lab in the midgut is expanded anteriorly in these embryos.)
The tritocerebrum-specific expression of the lab gene has been shown to be controlled by a 3.65 kb enhancer element upstream of the lab gene transcriptional start site (Chouinard and Kaufman, 1996; Hirth et al., 2001) . Given that early misexpression of a posterior Hox gene like Ubx results in a loss of lab transcripts in the tritocerebrum, we wanted to know if this repression of lab might be acting on the 3.65 kb enhancer element. To study this we utilized a transgene in which b-gal reporter gene expression was driven by the 3.65 Fig. 1 . Expression patterns of Gal4 drivers. Antibodies to Ubx were used to detect the responder UAS < Ubx under the control of three different Gal4 drivers. (A) sca < Gal4 expresses Gal4 during neuroectoderm specification and neuroblast formation starting from stage 9. (B) 1407 < Gal4 expresses Gal4 during neuroblast and ganglion mother cell formation and strong UAS activity is apparent by stage 12. (C) C155 elav < Gal4 expresses Gal4 in postmitotic neurons and strong UAS activity is apparent by stage 14. (A -C); embryos double-immunolabeled with a neuron-specific anti-HRP antibody (red) and an anti-Ubx antibody (green, yellow). Reconstructions of optical sections obtained by laser confocal microscopy; lateral views, anterior to the left. enhancer element, and which mimics endogenous lab expression in the intercalary segment, tritocerebral neuromere and anterior midgut (Fig. 6a, c) . This transgene was crossed into a sca < Gal4/UAS < Ubx genetic background and subsequently reporter gene activity in this line was studied. Initiation of reporter gene expression was seen at stage 9 in the neurogenic region of the intercalary segment that gives rise to the tritocerebrum (Fig. 6b) . However, starting at stage 10/11, reporter gene expression disappeared in the developing tritocerebrum (Fig. 6d) . This loss of labspecific reporter gene expression in the developing brain of sca < Gal4/UAS < Ubx embryos continued throughout embryogenesis.
From these experiments we conclude that the effect of early misexpression of a posterior Hox gene like Ubx on the developing tritocerebrum is due to cross-regulatory interactions which cause a transcriptional repression of the lab gene in the brain. This, in turn, results in an absence of Lab protein in the developing tritocerebrum from stage 10/11 onward and, correspondingly, gives rise to a lab lossof-function brain phenotype since this time period coincides with the temporal requirement of Lab for the specification of tritocerebral identity (Page, 2000; Hirth et al., 2001) .
In order to gain further insight into the molecular mechanisms that underlie this posterior dominance, Fig. 2 . Early, neuroectoderm-specific misexpression of Ubx, but not later misexpression of Ubx in the nervous system leads to a mutant brain phenotype. Different Gal4 drivers are used to misexpress Ubx. (A,B) Wildtype; (C,D) sca < Gal4/UAS < Ubx; (E,F) 1407 < Gal4/UAS < Ubx; (G,H) C155 elav < Gal4/UAS < Ubx. Only in the case of sca < Gal4/UAS < Ubx a brain patterning defect is observed in the tritocerebral domain (arrow in D, compare to wildtype in B). A,C,E,G; embryos double-immunolabeled with a neuron-specific anti-HRP antibody (red) and an anti-Ubx antibody (green, yellow); B,D,F,H; embryos immunolabeled with a neuron-specific anti-HRP antibody (red). Laser confocal microscopy of stage 13/14 embryos, reconstructions of optical sections, lateral views.
we carried out a set of sca < Gal4/UAS < Hox misexpression experiments involving posterior Hox genes such as Antp and Ubx with mutated protein motifs. To study the role of the homeodomain in the posterior dominance phenomenon, we focused on Antp and analysed the effect of sca < Gal4 driven misexpression of four different UAS constructs in which the DNA-binding activity of the Antp homeobox was perturbed. These were UAS < AntpDHD in which the homeodomain was deleted, UAS < AntpK50 in which the Antp DNA-binding specificity was changed to that of Bicoid, as well as UAS < AntpR5A and UAS < AntpA50A51 in which residues involved in DNA contacts were mutated in order to abolish binding to DNA (Plaza et al., 2001) . In all four cases, sca < Gal4 driven misexpression resulted in a wildtype-like embryonic brain (data not shown). This indicates a lack of repressive activity of Antp in the absence of a functional homeodomain.
To study the role of the conserved stretch of aminoacids termed the hexapeptide that is found in many Hox proteins and is involved in interactions between Hox proteins and Exd cofactor (Mann and Chan, 1996; Merabet et al., 2003) , we analyzed the effect of sca < Gal4 driven misexpression of a UAS < UbxYAAA transgene in which the critical YPWM motif of Ubx was mutated to the sequence YAAA (Galant et al., 2002) . Misexpression of the mutated Ubx gene under sca < Gal4 control resulted in a lab loss-offunction phenotype in the embryonic brain (data not shown), suggesting that the hexapeptide is not necessary for the suppressive effect of Ubx on lab action in the developing brain.
An analysis of the effects of interactions between Hox genes and Hth and Exd cofactors in anterior body segmentation has given rise to a model in which these cofactors are dispensable for Hox protein transcriptional repression functions, but are required for Hox protein transcriptional activation functions (Pinsonneault et al., 1997) . This model implies that Exd can convert Hox protein action from one functional state into another. Accordingly, we next investigated whether concomitant misexpression of Exd and Hth cofactors and a Hox protein like Ubx might be Fig. 3 . Mutant brain phenotype caused by misexpression of Ubx using the sca < Gal4 driver. (A,B) Immunolabeling with anti-ELAV (green); (C,D) Double-immunolabeling with anti-HRP (red) and anti-REPO (yellow/ green); (E,F) Double-immunolabeling with anti-HRP (red) and antiFasciclin II (yellow/green). In contrast to the wildtype situation (A), the neuron specific marker ELAV is missing in the tritocerebral domain of sca < Gal4/UAS < Ubx transgenic embryos (B, arrow). As in the wildtype (C), the glia-specific marker REPO is present in the tritocerebral domain of sca < Gal4/UAS < Ubx transgenic embryos, however, repo-expressing cells appear reduced in number and/or misplaced (D, arrow). Fasciclin II, which in the wildtype is expressed in the tritocerebral domain by a subset of neurons and their axons (E) is absent in sca < Gal4/UAS < Hox transgenic embryos (F, arrow). Laser confocal microscopy of stage 13/14 embryos, reconstructions of optical sections, lateral views. Fig. 4 . Absence of Labial protein results from early, neuroectoderm-specific misexpression of Ubx. (A) Wildtype, (B) sca < Gal4/UAS < Ubx. Doubleimmunolabeling with anti-LAB (red) and anti-ELAV (green) antibodies. In sca < Gal4/UAS < Ubx transgenic embryos, Labial protein as well as the neuron specific marker ELAV are missing in the tritocerebral domain (arrow in B; compare to arrow in A), whereas endoderm-specific expression of Lab in the midgut is ectopically expanded anteriorly (bracket in B, compare to A). Laser confocal microscopy of stage 13/14 embryos, reconstructions of optical sections, lateral views. Fig. 5 . Transcriptional repression of lab in the developing intercalary segment and tritocerebrum caused by sca < Gal4 driven UAS < Ubx misexpression. Whole mount in situ hybridization of labial transcripts in wildtype (A -C) and in sca < Gal4/UAS < Ubx (D-F) embryos; lateral views; anterior is to the left. At stage 9, lab expression is detectable in both wildtype (A) and sca < Gal4/UAS < Ubx (D) embryos in the neurogenic region of the intercalary segment (arrow) that gives rise to the tritocerebrum as well as in the developing midgut. Subsequently, in sca < Gal4/UAS < Ubx embryos, lab transcripts disappear in the developing tritocerebrum and from stage 10/11 onwards are completely absent in the developing brain (arrows in E, F; compare to B,C). (Note that endoderm-specific expression of lab in the midgut is ectopically expanded anteriorly; bracket in F, compare to C). able to convert or cancel the repressive effect of Ubx misexpression on lab transcription. To investigate this, we used the sca < Gal4 driver in combination with UAS < Ubx, UAS < exd, UAS < n-exd and UAS < hth responders to misexpress Ubx and these cofactors together. Combined misexpression of the Hox gene Ubx with either exd, or nuclear exd (n-exd), or hth did not alter the repressive effect of the Hox gene on the developing tritocerebrum (data not shown). (Control experiments in which either exd, n-exd or hth were misexpressed under the control of sca < Gal4 but without concomitant misexpression of a Hox gene resulted in a wildtype-like brain.) In contrast, when Ubx was misexpressed together with both n-exd and hth, a complete phenotypic rescue of the tritocerebral defect was observed (Fig. 7) . Thus, the tritocerebral neuromere developed normally and both commissural and longitudinal pathways were restored. Moreover, normal expression of the Lab protein was seen in the appropriate tritocerebral domain. This indicates, that early CNS-specific misexpression of n-exd and hth encoded cofactors combined with early CNS-specific misexpression of Ubx cancels the repressive effect of Ubx on lab expression in the tritocerebral domain. This phenotypic rescue was not observed when a mutated UbxYAAA was misexpressed together with n-Exd and Hth (data not shown), suggesting that Ubx with a functional hexapeptide and the cofactors n-Exd and Hth are required to convert or cancel the repressive effect of Ubx misexpression on lab transcription.
Discussion
The main function of Hox genes is to assign positional identities along the embryonic body axis in animals ranging from arthropods to vertebrates (McGinnis and Krumlauf, 1992; Manak and Scott, 1994; Carroll, 1995) . Several mechanistic paradigms have been proposed to describe Hox gene action, two of which are the concepts of cross-regulation among Hox genes, and of co-operative interactions between Hox genes and protein cofactors (Duboule and Morata, 1994; Graba et al., 1997; Mann and Morata, 2000) . In the developing CNS of Drosophila, lossof-function studies have shown that Hox genes expressed in more posterior regions act as negative regulators of Hox genes that are expressed in more anterior regions of the CNS. For example Antp is primarily expressed in Parasegment (PS) 4 and PS5 of the CNS, but it is also expressed at lower levels in PS6-13 (Levine et al., 1983; Hafen et al., 1984; Carroll et al., 1986; Hirth et al., 1998) . In embryos that lack the Bithorax-complex genes, Antp expression is high in PS4-13 (Hafen et al., 1984; Harding et al., 1985; Carroll et al., 1986) , suggesting that BX-C gene action keeps Antp expression low in PS6-13. Similarly, BX-C genes that are expressed and function in more posterior abdominal segments keep Ubx expression low in PS7-13. In the absence of the abdominal BX-C genes, Ubx products are found at high levels in PS6-13 (Struhl and White, 1985; White and Wilcox, 1985) . In addition, recent gain-of-function experiments have shown that ectopic Ubx and Abd-A are able to repress lab and Scr in the CNS in a timing dependent manner while otherwise overlapping expression of other Hox genes is tolerated . In our analysis, we have focused on lab, the Hox gene specifically expressed in the tritocerebral neuromere. Genetic analyses have shown that lab is essential for the acquisition of neuronal identity in its tritocerebral expression domain, and lab loss-of-function mutations lead to severe defects in the establishment of the tritocerebral neuromere (Hirth et al., 1998) . The action of lab in this domain can be eliminated by targeted misexpression of posterior Hox genes through the sca < Gal4 driver, resulting in a lab loss-of-function phenotype in the brain. This suppression of lab action has a number of features that are characteristic of the type of crossregulatory Hox gene interactions that have been demonstrated in developing epidermal structures . First, the suppression of lab in the tritocerebrum appears to be time dependent. While early misexpression of posterior Hox genes during neuroectoderm specification and neuroblast formation at embryonic stage 9 reliably results in lab suppression in the tritocerebrum, later misexpression, after embryonic stage 10/11, does not. Second, lab suppression by misexpression of posterior Hox genes is tissue specific. Thus, while Hox gene misexpression via the sca < Gal4 driver suppresses lab expression in the tritocerebrum, it augments lab expression in the endodermal cells of the midgut. Third, misexpression of posterior Hox genes leads to a loss of Lab protein in the affected domain, and this lack of Lab is in accordance with the observed phenocopy of a lab loss-of-function mutation observed in this domain.
In several respects these experiments extend our insight into cross-regulatory interactions beyond the observations made on developing epidermal structures. We provide evidence that the suppression of lab by a posterior Hox gene like Ubx is due to transcriptional repression. Thus, in sca < Gal4/UAS < Ubx embryos, lab transcripts disappear and are absent in the developing tritocerebrum from stage 10/11 onward. This tritocerebrum-specific repression appears to be mediated through a 3.65 kb enhancer element upstream of the lab gene transcriptional start site. Moreover, our results imply that suppression of lab in the developing tritocerebrum by posterior Hox genes requires a functional homeodomain; mutations of the homeodomain in the Antp gene abolish the repressive activity of this Hox gene. In addition, our findings indicate that the suppressive cross-regulatory action of a posterior Hox gene like Ubx is not dependent on a functional hexapeptide. Thus, misexpression of a UAS < UbxYAAA transgene in which the critical YPWM motif of Ubx was mutated to the sequence YAAA (Galant et al., 2002) , still results in complete suppression of lab in the developing tritocerebrum. Finally, we provide evidence that concomitant misexpression of Ubx, nuclear-targeted Exd and Hth is able to completely rescue the lab loss-of-function mutant phenotype. This implies that the Exd and Hth cofactors can switch Ubx protein action between different functional states in which Exd and Hth are required for Hox protein transcriptional activation functions whereas they are dispensable for Hox transcriptional repression functions (Pinsonneault et al., 1997; Li et al., 1999) . Moreover, our findings can be explained by models in which the hexapeptide is involved in the regulation of Hox protein activity (Merabet et al., 2003; In der Rieden et al., 2004) , and may also reflect a requirement for equilibrated levels of a Hox gene product and the Hth and n-Exd cofactors in the specification of tritocerebral identity.
Experimental procedures

Fly strains and genetics
The Yeast Gal4 transcriptional activation system (Brand and Perrimon, 1993) was utilized in order to ectopically express UAS/Gal4 responder constructs at various time points during CNS development of Drosophila. This was accomplished with three different Gal4 driver lines: sca < Gal4 (Klaes et al., 1994) , an enhancer trap line which expresses Gal4 during neuroectoderm specification and neuroblast formation; 1407 < Gal4 (Broadie et al., 1995 . courtesy of J. Urban), an enhancer trap line that expresses Gal4 during neuroblast and ganglion mother cell formation; and C155 elav < Gal4 (Lin and Goodman, 1994) , an enhancer trap line that expresses Gal4 in postmitotic neurons.
For targeted ectopic expression of Hox genes, the following responder lines were used: Pðw þmC ; UAS < lab) 2.4a ; Pðw þ ; UAS < pb) 49.1 (Aplin and Kaufman, 1997) ; Pðw þmC ; UAS < Dfd) pC41 (Brown et al.,1999) ; Pðw þmC ; UAS < Scr) EE2 ; Pðw þmC ; UAS < Antp) W2 ; Pðw þmC ; UAS < Ubx) M2A (Ia isoform of Ubx) ; P{w þmC ¼ UAS-Ubx.Ia.C}36.2 (supplied by M. Akam); Pðw þ ; UAS < abdA) 21.6 (Greig and Akam, 1993) ; w 1118 ; Pðw þ ; UAS < AbdBm) 1.1 c23 (morphogenetic isoform of AbdB) (Castelli-Gair et al., 1994) . In addition, we used the following UAS responder lines: Pðw þmC ; UAS < dAntp) (Plaza et al., 2001 ); Pðw þmC ; UAS < AntpA50,51) (Plaza et al., 2001) ; Pðw þmC ; UAS < AntpQ50KC) (Capovilla et al., 2001) ; Pðw þmC ; UAS < Ubx YAAA) (Galant et al., 2002) ; P(UAS < hth) (Pai et al., 1998) ; P(UAS < FLAG < NLS < EXD) (Jaw et al., 2000) . UAS < responder transgene activity was confirmed by immunoreactivity.
For a detailed analysis and comparison of the tritocerebral phenotype resulting in sca < Gal4/UAS < Hox lines, we used the lab vd1 null mutant allele (Merrill et al., 1989; Hirth et al., 1998) , balanced over TM3, Ubx-lacZ. Homozygous null mutants were identified by the absence of Ubx-lacZ. To identify former lab expressing tritocerebral cells in the sca < Gal4/UAS < Hox background, we used line P{w þ 3.65 lab-lacZ} (Chouinard and Kaufman, 1996; Hirth et al., 2001) . P{w þ 3.65 lab-lacZ} shows nuclear distribution of bgal and reflects endogenous lab expression in the embryonic head ectoderm, tritocerebrum, and posterior midgut. In order to rescue the tritocerebral brain phenotype obtained by sca < Gal4/UAS < Hox, the following genotypes were generated and analysed: sca < Gal4=þ; PðUAS<hthÞ; P{w þmC ¼UAS-Ubx:Ia:C} 36:2 sca<Gal4=Pðw þmC ;UAS<UbxÞM2A;PðUAS<FLAG< NLS < EXDÞ=þ sca<Gal4=þ; PðUAS<hthÞ; P{w þmC ¼UAS-Ubx:Ia:C} 36:2=PðUAS<FLAG-NLS-EXDÞ sca<Gal4=þ; Pðw þmC ;UAS<UbxYAAAÞ=þ; PðUAS< FLAG-NLS-EXDÞ; PðUAS < hthÞ;
UAS < responder transgene activity for these genotypes was confirmed by immunoreactivity, except for the recombinant chromosomes PðUAS<hthÞ; P{w þmC ¼ UAS-Ubx:Ia:C } 36:2 and PðUAS < FLAG-NLS-EXDÞ; PðUAS<hthÞ; where immunoreactivity was carried out only for one of the designated UAS responders (either Hth or Ubx, or either Exd or Hth). All experiments reported here were carried out at 25 8C; no significant differences were obtained when experiments were carried out at 28 8C. Embryos were staged according to Campos-Ortega and Hartenstein (1997) .
Immunocytochemistry
Embryos were dechorionated, fixed and labeled according to Therianos et al. (1995) . Primary antibodies were rabbit anti-HRP (FITC-conjugated) 1:100 (Jan and Jan, 1982) (Jackson Immunoresearch), rabbit anti-LAB (F. Hirth and H. Reichert, unpublished) at 1:100, rat anti-LAB (F. Hirth and H. Reichert, unpublished) at 1:500, rabbit anti-PB (Pultz et al., 1988) at 1:200, guinea pig anti-DFD (Kuziora and McGinnis, 1988) at 1:200, rabbit anti-SCR (LeMotte et al., 1989) at 1:200; mouse anti-ANTP 1:100 (Condie et al., 1991) , mouse anti-UBX 1:5 and mouse anti-ABD-A 1:100 (A. Macias and G. Morata, unpublished), mouse anti-ABD-B 1:1 (Celniker et al., 1989) , rabbit anti-bGAL 1:400 (Milan Analytika), mouse anti-bGAL 1:100 (DSHB), mouse antiFasciclin II 1:5 (Lin and Goodman, 1994) , rat anti-ELAV 1:30 (DSHB), mouse anti-REPO 1:20 (DSHB), rabbit anti-HTH (Pai et al., 1998) at 1:200, and monoclonal mouse anti-EXD at 1:2 (Aspland and White, 1997) . As secondary antibodies we used the respective Alexa-488, Alexa-568, and Alexa-647 antibodies generated in goat (Molecular probes), all 1:150. Embryos were mounted in Vectashield H-1000 (Vector).
Laser confocal microscopy
For laser confocal microscopy, a Leica TCS SP was used. Optical sections ranged from 0.4 to 2 mm recorded in line average mode with picture size of 512 £ 512 pixels. Captured images from optical sections were arranged and processed using IMARIS (Bitplane). Figures were arranged and labeled using Adobe Photoshop and Power Point.
